The global anesthesia and respiratory devices market is highly concentrated, with a small number of large players constituting half of the total share. The top ten competitors in the market made up to 50.27% of the total market in 2018. The development of new devices due to the need for advanced and innovative new equipment increases market completion. Resmed Inc. was the largest competitor with 11.33% of the market in 2018, followed by General Electric Company with 7.21%. Other major players in the market include Koninklijke Philips N.V., Cardinal Health, Inc., Medtronic Plc, Fisher & Paykel Healthcare Corporation Limited, Draegerwerk AG, Vyaire Medical, Inc., Teleflex Inc., and Smith Group Plc.
Resmed Inc., the largest competitor in the global anesthesia and respiratory devices market in 2018, develops, manufactures and markets medical devices and cloud-based software applications related to the treatment of sleep-related breathing disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company was founded in 1989 and is headquartered in San Diego, California, United States. Resmed employs approximately 6,000 people globally. Resmed Inc. generated revenues of $2.34 billion for the financial year 2018 from the anesthesia and respiratory devices market, a 13.2% increase from the previous year.
Resmed’s growth strategy aims at expanding its business into high growth geographic areas, including China, India, Eastern Europe, Brazil and Southeast Asia, and focusing on new product developments and innovations in respiratory care products. In 2016, the company acquired Curative Medical to invest in China’s market and expand its growth potential in SDB (sleep-disordered breathing), COPD and respiratory care in China. Again, in 2018, Resmed invested $155.1 million in the research and development of new products and also introduced Mobi, a portable oxygen concentrator, which is ideal for oxygen patients with chronic obstructive pulmonary disease.
General Electric Company was the second largest competitor in the anesthesia and respiratory devices market in 2018. It offers products and services ranging from aircraft engines, power generation and oil and gas production equipment, to medical diagnostic and imaging equipment, and financing and industrial products. The company was founded in 1892 and is headquartered in Boston, Massachusetts, USA. The company employs approximately 283,000 people globally. General Electric Company generated estimated revenues of $1.49 billion for the financial year 2018 from the anesthesia and respiratory devices market, a 2.8% increase from the previous year.
General Electric Company’s subsidiary GE Healthcare’s growth strategy aims at expanding the opportunities in ventilation therapy through collaborations. For instance, in November 2018, the company collaborated with Italy-based Siare Engineering International Group S.R.L. to add Siare ventilators into its current ventilator product portfolio. The strategic alliance is expected to strengthen GE Healthcare’s presence in performance range, value, and mid-tier range ventilator products.